Structure (Tra08 0004 01)
Trandate
Product Images NDC 65483-392
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Trandate (NDC 65483-392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prometheus Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
100 mg 100ct Bottle Label (Tra08 0004 02)
This is a description for Trandate (labetalol hydrochloride) tablets. Each tablet contains labetalol and there are 100 tablets in a package. Dosage and administration can be found in the package insert. Store the medicine between 2°C and 30°C (36°F and 86°F) in tight containers as per the USPNE definition. Trandate tablets are manufactured by WelSpring Pharmaceutical Canada Corp. for Prometheus Laboratories Inc, San Diego. This information is copyrighted by Prometheus Laboratories Inc., and all rights are reserved. The product is made in Canada.*
200 mg 100ct Bottle Label (Tra08 0004 03)
This is a description of a medication called Trandate, also known as labetalol hydrochloride. The medication comes in tablet form and dosage information can be found on the package insert. It should be stored at temperatures between 2°C and 30°C. The manufacturer is WeliSpring Pharmaceutical Canada Corp, located in Oakville, ON L6H 1MS and it is distributed by Prometheus Laboratories Inc. in San Diego, CA. It is copyrighted by Prometheus Laboratories Inc. and was made in Canada.*
300 mg 100ct Bottle Label (Tra08 0004 04)
Trandate® (labetalol hydrochloride) tablets are to be stored between 2° and 30°C, and dispensed in tight containers manufactured by Welsping Pharmaceutical. Dosage and administration information is in the package insert. The tablets are produced by Prometheus Laboratories Inc. and have the NDC code 65483-393-10. Each tablet contains 300 mg of labetalol hydrochloride and is for Rx only use. This information is copyrighted by Prometheus Laboratories Inc. and the tablets were made in Canada in Nov. 2002.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
